Objective: Successful animal and clinical implantation of decellularised heart valves has been performed in the pulmonary position. Comparable results have not yet been achieved for the aortic position with the high haemodynamic demands of the systemic circulation and the challenging implantation procedure. Methods: Allogenic aortic valves (n = 10) were decellularised using detergents (decellularised aortic valves (dAoVs)). Five prostheses were analysed for decellularisation quality and scaffold preservation. Five valves were orthotopically implanted in juvenile sheep in a subcoronary technique. After 5 months, echocardiography, immunohistology, histology, electron microscopy and western blot (WB) were used for analysis. Results: All animals survived the follow-up with increased body weight (38.8 AE 2.8 kg vs 56.0 AE 2.6 kg, p < 0.001). After implantation, three dAoVs showed negligible and two others minor insufficiency (I), which remained unchanged at explantation. Effective orifice area increased slightly (1.1 AE 0.2 cm 2 vs 1.6 AE 0.3 cm 2 , p = 0.051). Explanted dAoVs (n = 4) showed excellent macroscopy with minor soft-tissue nodules observed at the free cusp margins of only one dAoV. No valve showed any signs of thrombosis or calcification. On microscopic evaluation, the cusp architecture was preserved with an almost complete endothelial repopulation as confirmed by vimentin + /von Willebrand factor (vWF + )-staining, WB of endothelial markers (eNOS/vWF) and scanning electron microscopy (SEM). Partial interstitial reseeding with vimentin + /alpha-smooth muscle (asm + )-cells was noted. Quantitative measurement of collagen-IV, collagen-I, laminin and elastin (WB) demonstrated preserved scaffold composition as compared to native tissue. Conclusion: The dAoVs showed excellent functional outcome at 5 months in a subcoronary model of juvenile sheep. Advanced endothelial and nascent interstitial repopulation, with preserved structural integrity under the high-shear-stress milieu of the aortic valve, encourage further long-term studies. #
Objective
Aortic valve disease necessitating operative or interventional treatment is one of the worldwide leading causes for morbidity and mortality with an increasing prevalence in the elderly population. Currently, available heart-valve prostheses show substantial limitations in terms of long-term durability or freedom from serious life-threatening events [1, 2] . Novel heart-valve prostheses, such as polymer-based prosthesis or detergent decellularised heart valves (dHVs), have been developed to overcome the existing limitations of current heart valves [3, 4] . Among the various existing concepts, dHVs have been proven to be the most promising solution in vivo, when applied to the pulmonary position, either with autologous reseeding or without an in vitro repopulation [5] . The reports on successful application of pulmonary dHV include experimental trials and even a few selected clinical cases [6] . We and other groups have shown the excellent long-term functional outcome of dHVs in a sheep model [5] . After 9 months in vivo, explanted valves show advanced endothelialisation and also partial interstitial repopulation. Immunohistolochemical signs of extracellular matrix (ECM) synthesis have been detected in experimental specimens, for example, pro-collagen expression; moreover in experimental trials as well as in clinical cases, additional evidence from follow-up echocardiographic studies have given rise to the hope of possible growth capacity of dHVs when implanted in paediatric or juvenile recipients in the pulmonary position [6] .
In contrast, data on the performance of dHVs in the aortic position have been lacking for a long time, presumably due to the significantly higher demands of the systemic circulation.
Hence, an early mechanical failure due to the high-pressure gradients across the aortic valve or a functional impairment due to enhanced degeneration during long-term follow-up have been among the major concerns. This is the first, worldwide report on the functional performance and structural maturation of dHVs implanted in the subcoronary position in a growing ovine model.
Methods
All animal experiments and surgical procedures were performed in compliance with the Guide for the Care and Use of Laboratory Animals as published by the US National Institutes of Health (NIH Publication 85-23, revised 1996) and were approved by the local animal-care committees (registr. nr. 35-9185.81/G165/07). The authors had full access to the data and take full responsibility for data integrity. All authors have read and agree with the manuscript as it is written.
Decellularisation
Decellularisation of juvenile ovine aortic valves (n = 10, donors weighing 35-45 kg) was performed by using a modified detergent-based protocol initially introduced by Borschel et al. [7] . In brief, aortic heart valves were subjected to 72-h incubation periods with alternating solutions of 80% glycerin/25 mM ethylene diamine tetraacetic acid (EDTA), 4.2% sodium deoxycholate, 1% sodium dodecyl sulphate (SDS) or 3% Triton X-100 in the presence of 0.05% sodium azide (NaN 3 ). Decellularisation was finalised by a 72-h rinsing step in phosphate-buffered solution (PBS). Solutions were changed every 12 h. All valves were subjected to an in vitro sterility testing prior to further processing. Five valves were used to determine the extent of decellularisation and scaffold preservation; five decellularised aortic valves (dAoVs) were implanted for the in vivo study.
Implantation of aortic valves
Decellularised aortic valves were prepared by excision of most of the aortic wall, sparing only the proximal part of the sinus ( Fig. 2A) . Under cardiopulmonary bypass and cardiac arrest induced by modified Buckberg cold cardioplegia, dAoVs were implanted into Merino lambs (age: 14-20 weeks, weight: 30-40 kg, obtained from the local breeder (Baden Württemberg)) in a subcoronary technique. In brief, the valves were prepared by resection of most of the sinus tissue leaving a narrow margin of the implant aortic sinus tissue. The valve was placed in the annulus and inverted by pushing the commissural junctions through the orifice towards the ventricular cavity. Now, the narrow myocardial cuff of the implant was anchored on a subvalvular level by a row of single stitches (prolene 4/0). After repositioning the valvular tissue out of the left ventricular outflow tract (LVOT) into the correct position, a second row of running sutures (prolene 5/ 0) was used for the fixation of the implant sinus margins to the recipient's aortic sinus. Perioperative management of the animals was performed as described before [5] . Animals were kept under close observation at the core facility for 5-7 days before returning to the original breeding farm, where the animals were kept until terminal explantation.
Based on our previous in vivo experience with dHVs containing an intact basal lamina, no anti-platelet medication or anticoagulation was applied in the postoperative period in this series.
Echocardiography
Echocardiography was performed immediately after surgical implantation and subsequently at the time of explantation 5 months postoperatively using a Sonos 2500 (Phillips) as previously described [8] . LVOT and aortic valveorifice area (AVA) were determined. Measured functional parameters included maximal and mean gradients through the aortic valve, and the grade of valve regurgitation according to the standard grading system for AoV.
Explantation of aortic valves
After administration of heparin (300 IE/kg of body weight), animals were euthanised (pentobarbital 1 ml/kg of body weight, intravenous; Provet). The AoV was excised under aseptic conditions after measurement of the AoV dimensions using standard aortic heart-valve sizers (SJM). Following macroscopic examination, all explants were photographically documented.
Histology and immunohistochemistry
For histological analysis, specimens of valvular leaflets were formalin fixed and paraffin embedded. Haematoxylineosin (H&E), Movat Pentachrome or von Kossa staining was obtained from 5-mm tissue sections. For immunohistochemistry, 3-mm sections were deparaffinised following standard techniques. Antigen retrieval was performed by microwave treatment with Tris-hydrochloric acid (HCl) buffer, followed by washing steps with PBS [9] . Non-specific reactions were blocked with milk powder in PBS containing TX-100 followed by antibody incubations.
Scanning and transmission electron microscopy
For scanning electron microscopy (SEM), samples were fixed in 2.5% glutaraldehyde (Polyscience) in 0.1 mol l À1 sodium cacodylate buffer (Merck) and processed as described previously. Briefly, samples were dehydrated in an ascendingconcentration series of ethanol. Following critical pointdrying (Balzers CPD 030), samples were sputtered with an ultrathin gold layer (Polaron SEM Coating System) and examined by SEM (Phillips SEM-505).
For transmission electron microscopy (TEM) samples, small tissue pieces were fixed in 2.5% glutaraldehyde in 50 mM cacodylate buffer containing 50 mM potassium chloride (KCl) and 2.5 mM magnesium chloride (MgCl 2 ) and post-fixed with 2% osmium tetroxide (OsO 4 ), following an overnight incubation with 0.5% uranylacetate in water. Pieces were dehydrated and embedded in Epon [10] . Ultrathin sections were stained with 2% uranylacetate in methanol and lead-citrate and observed with a Zeiss EM 900.
DNA, RNA and protein isolation and quantification
DNA, RNA and protein were isolated from 30 mg of explanted valve tissue (cusps) using the ALLPrep DNA/RNA/ Protein Mini Kit (Qiagen) following the manufacturer's protocol.
Briefly, homogenised tissue lysates were passed through an ALLPrep DNA spin column, which selectively binds DNA. The column was washed, and DNA was eluted. Using appropriate buffer conditions, total RNA was isolated from the flow-through of the ALLPrep DNA spin column by binding to an RNeasy spin column. Total protein was then extracted from the flow-through of the RNeasy spin column under specified buffer conditions. DNA, RNA and protein (BCA protein assay kit; Sigma) quantification was carried out photometrically (BioPhotometer; Eppendorf).
Western blotting
Total protein homogenates (30 mg) were denatured, separated on SDS-polyacrylamide gel electrophoresis (PAGE) gradient gels (Invitrogen) and transferred to polyvinlylidene fluoride (PVDF) membrane (Invitrogen). The blots were probed with antibodies specific to extracellular matrix proteins: laminin (1:500, Chemicon International), elastin (1:200, Santa Cruz Biothechnology) and collagen type I (1:500, Chemicon). The integrity of the basement membrane was evaluated by probing blots with collagen type IV antibody (1:500, Santa Cruz Biothechnology). Endothelial cell (EC) phenotype was characterised using primary antibody against von Willebrand factor (vWF; 1:1000, Dako Cytomation) and alpha-Tubulin (1:1000, Sigma). The immunoreactive protein bands were developed using the Enhanced Chemiluminescence system (ECL Plus, PerkinElmer). Protein-band densities were obtained and relative amounts of the ECM components laminin, elastin and collagen type IV based on collagen type I were calculated. For ECM proteins, the most abundant protein, collagen type I, was used as a reference parameter to obtain indexed values for the analysed individual proteins. Likewise, for the cellular vWF predominantly expressed by ECs, the protein-band density of the common cell-protein tubulin was used as a reference parameter. The cusp tissue of a native ovine aortic valve served as the control.
Quantitative ECM assessment
The ECM was further characterised by analysing the sulphated glycosaminoglycan (S-GAG) content using the Blyscan Sulphated Glycosaminoglycan Assay kit (Biocolor Ltd). Briefly, representative portions of explanted valve tissue were weighed and extracted overnight using freshly prepared Pronase solution (Roche) at 37 8C with rotation. Total S-GAG content was measured according to the manufacturer's protocol. Absorbance was read at 656 nm and the amount of S-GAG was calculated from a calibration curve for standard S-GAG. Fresh native AoV (n = 3) and dAoVs (n = 5) were analysed for the tissue content of glycoaminoglycans by using a colorimetric assay (Blyscan Glycosaminoglycans Assay, Biocolor). The GAG content was pelleted for 10 min at 13 000 rpm after prior specimen treatment with pronase (2 mg ml À1 ) and incubation with Blyscan dye reagent. After resuspension, colorimetric determination of GAG content was performed by measurement of the extinction at 656 nm using a standard enzyme-linked immunosorbent assay (ELISA) reader and predefined standard curves.
Statistical analysis
All data were recorded as mean AE standard deviation (SD). A paired Student's t-test was used for analyses. Statistical significance was defined as a p-value <0.05. A statistical software package for Windows (SPSS, v. 11.0) was used to carry out the statistical analysis.
Results

Extent of decellularisation and morphology of dAoV
Decellularisation of the AoV (Fig. 1A) according to the presented protocol resulted in complete removal of cellular components as determined by histology, demonstrated by H&E and Movat Pentachrome stainings ( Fig. 1B and C) . Using a protocol based on detergents, decellularisation of donor aortic valves with similar results as previous reports on pulmonary valves could be achieved. Residual total DNA content was negligible as compared to native tissue samples (data not shown). As previously shown, morphological analysis on histological and ultra-structural level revealed an efficiently preserved three-dimensional scaffold composition. A threelayered leaflet architecture with remarkable amount of elastic fibres was demonstrated by Movat Pentachrome (Fig. 1B) . By TEM examination, the dAoVs displayed dense collagen-fibre bundles with dramatically reduced cellular components (Fig. 1D) . Only in very few sections were structures resembling cellular remnants or debris detected on the dAoV leaflets (Fig. 1E) . By quantitative measurement, the GAG content for the dAoV was 159.1 AE 77.1 mg g À1 tissue as compared to 150.4 AE 34.2 mg g À1 tissue for the native AoV ( p = n.s.). SEM confirmed complete preservation of the basement membrane (BM) on both sides of the leaflet, as expected for a nonenzymatic protocol (data not shown).
Follow-up period
All five animals survived the operative procedure and were electively explanted 5 months after the operative procedure. The postoperative course remained uneventful. All animals increased body weight during the follow-up period by 1.45 times the baseline (38.8 AE 2.8 kg vs 56 AE 2.6 kg, p = 0.003).
Echocardiography and transvalvular pressure gradient
Echocardiographic data are presented in Table 1 . Immediately after implantation, three dAV showed negligible and two other minor insufficiencies (I8s), which remained unchanged at explantation. The effective orifice area (EOA) increased slightly with a strong tendency of the dAoV to show an EOA increase, although formal statistical significance of p < 0.05 was missed in this small cohort (1.1 AE 0.2 cm 2 vs 1.6 AE 0.3 cm 2 , p = 0.054). No significant stenosis and no gross morphological changes were observed on echocardiography; transvalvular pressure gradients (TPGs) at explantation were similar to the values obtained immediately after implantation.
Macroscopic evaluation at explantation
Macroscopic view of the operative field revealed no signs of an augmented inflammatory reaction or excessive adhesions. In four of five explants, excellent macroscopic appearance with an intact cusp morphology (Fig. 2B) defined by smooth and translucent cusp tissue was observed, comparable to native tissue. No signs of thrombosis or focal tissue hyperplasia was observed (n = 4). In one explant, minor soft-tissue nodules without functional correlation in the echocardiography (Fig. 2C) were observed. No vegetation, fenestration or signs of calcification were observed. In all valves, the implanted AoV in the subcoronary position was found in the correct position in relation to the coronary ostia, thus allowing for free coronary inflow through unremarkable ostia ( Fig. 2B and C) . Intraoperative echocardiographical examination at the time of implantation and explantation of decellularized aortic valves (dAoV) reveals no statistically significant changes over the period of the experiments. LVOT: left ventricular outflow tract; AVA: aortic valve area.
Fig. 2. Decellularized aortic valve prior to implantation and after 5 months in vivo.
Prior to implantation dAoV are prepared by resection of the aortic sinus leaving only a sewing cuff on the ventricular and aortic side (A) allowing for secure anchorage of the prosthesis without coronary obstruction (black arrows, B and C). At 5 months in vivo an excellent macroscopic appearance of the leaflet demonstrates the structural integrity (B), with only one valve displaying minor soft-tissue nodules without functional correlate in the echocardiography (white arrow, C). Fig. 3 . Repopulation of dAoV. After 5 months in aortic position, dAoV are partially repopulated with a greater progression of the recellularisation at the base, here also beginning interstitial repopulation with a-sma + cells was observed (A and B). Furthermore, an endothelial lining with vimentin + cells was also observed at the mid and tip portion of the valve (C-E), although endothelial gaps were evident towards the free margin of the cusps (F). Haematoxylin and eosin (A and D), anti-sma-staining (B), anti-vimentin-staining (C and E), SEM scanning electron microscopy (F).
Repopulation of dAoV
AoVs explanted after 5 months showed a de novo endothelial layer (Fig. 3A and D) with typical cobblestonelike ECs as demonstrated by SEM. The endothelial coverage of the valves proved complete for the arterial surface (Fig. 3E) . On the ventricular surface, particularly towards the tip of the free margin of the cusps, gaps in the endothelial layer were detected in histological as well as SEM images (stars, Fig. 3E  and F) . The cells lining the endothelial surface were positive for the mesenchymal marker vimentin (Fig. 3C and E) , but negative for alpha-smooth muscle actin (asm-actin; Fig. 3B ). Abundant asm-actin + -cells were present at the base of the cusp with conical invasion into the cusp tissue, which was, for all explants, more enhanced on the ventricular side (Fig. 3B) . The observed trend towards higher-indexed vWF content might be explained by the large proportion of EC within all existing cells in the dAoV as compared to native AoV. In contrast, in the native valve tissue the endothelial layer, as the main source for vWF, accounts for a smaller cell fraction and thus the indexed vWF content tends to be lower (Fig. 5 ).
ECM maturation
In explant tissues, von Kossa staining showed no calcification in the implanted dAoV. This finding was consistent in all explants for all valve regions, from the densely populated base to the rarely populated free margin of the cusps (Fig. 4A-C) . On Movat pantachrome staining, differences in the pictures of the ECM as compared to the native AoV became visible with a change of the overall composition of the ECM, although a three-layered order of the ECM was preserved. A quantitative analysis of major components of ECM was carried out by means of western blot (WB) and by applying a quantitative colorimetric assay. The relative tissue content of GAGs was comparable with that of the native tissue (190.6 AE 29.1 mg g À1 tissue vs 150.4 AE 34.2 mg g À1 tissue, p = n.s.; Fig. 5 ). By means of WB, a preserved proportion of laminin and collagen type IV, two pivotal components of the basal lamina, could be demonstrated as was a comparable elastin content for dAoV.
Discussion
The dHVs have already entered the clinical arena in the low-pressure pulmonary position. Their future value for the clinically more relevant aortic position remains yet to be elucidated. To our knowledge, this is the first report on the mid-term in vivo performance of dAoVs in an ovine subcoronary-implantation model. Our results demonstrate that detergent dAoVs may serve as suitable substitutes of the aortic valve allowing for superior haemodynamics without any clinically relevant structural deterioration for up to 5 months.
In this study, a preserved macroscopic morphology of the dAoV was observed at explantation. An endothelial lining of the valve-surface area was detected, although coverage was not fully complete, particularly towards the free cusp margins. The principal finding of a spontaneous in vivo endothelialisation and the underlying pattern of basetowards-tip progression is in line with previous reports by our group and others on decellularised pulmonary valves [5, 11, 12] . However, considering the high-pressure conditions at the level of the aortic valve, the extent of this process appears remarkable. Whether an in vitro endothelialisation, with or without physiological conditioning of the valve prior to implantation [5] , might have a long-lasting beneficial effect on surface morphology of implants in the aortic position remains to be evaluated. However, the performance of dAoVs and the absence of a major thrombotic process in the analysed group speak in favour of the protocol presented in this report. Nevertheless, it may be speculated that, under the high-pressure-high-shear-stress conditions of the aortic valve, thrombotic formations shortly after their initiation may be rather more prone to a 'wash-off' phenomenon than is the case in the pulmonary position with lower flow velocity and pressure values. In a very recent report, Baraki et al. have presented an ovine model of aortic valve implantation as full root replacement by using decellularised valvebearing conduits [13] . In their series, Baraki et al. have performed an initial anticoagulation treatment to prevent thrombotic events and they observed no valve thrombosis or sympotomatic embolisation. Notably, no anticoagulation regimen was applied and no thrombocyte inhibitors were administered in this study. The absence of clinically relevant thrombo-embolic events during the follow-up period and the intact valve morphology at explantation may be partially attributed to the specific surface characteristics of the basal lamina, which may be preserved during detergent-based decellularisation [14] . However, the special haemodynamics of the aortic position may partially be responsible for the favourable outcome. We observed a slight trend towards smaller amounts of collagen type IV and elastin, whereas a trend towards higher amounts in the explants was observed for laminin. We observed widely preserved ECM components, such as laminin, collagen type IV, elastin and GAG. Trends in changes might be related to the extracted cellular protein mass in dAoV causing a shift in the relative protein proportions. Similarly, for GAG, an apparent increase of the indexed amount (per gram of tissue) was observed, which may be explained by the diminished tissue mass after decellularisation.
In this series, at explantation, echocardiography revealed larger AVAs than at implantation while all animals displayed substantial somatic growth during the follow-up period. Thus, the question on the growth capacity of decellularised or tissue-engineered heart valves arises. The interpretation of these and similar observations of other studies remains controversial. Whereas theoretic considerations and some measured parameters support the idea of growth, passive dilatation of the aortic valve ring in the setting of compensated leaflet coaptation may well be the underlying principal mechanism. Considering the asymmetrical cellular repopulation at 5 months in vivo, regenerative potential, as it is linked to turnover of cellular and extracellular components, most probably will be predominantly located at the cell-dense basal areas. We have observed the abundant presence of cells of mesenchymal origin and also a large population expressing asm-actin. A more detailed study of the specific cell types involved in the repopulation of dAoV and their contribution to ECM degradation and de novo synthesis might shed a brighter light on the controversial subject of in vivo regeneration of dHVs.
One of the advantages of the hereby-proposed model of subcoronary implantation of dAoV may lie in the minimised amount of implanted tissue without functional relevance, for example, the aortic wall in the area of the aortic sinus. As performed in the vast majority of clinical cases, replacement of diseased aortic cusp tissue by a healthy and functional valve defines the standard procedure in aortic valve replacement. When decellularised tissue is used for implantation, at least three further considerations deserve particular attention. The extent and the speed of repopulation of a dAoV cusp are expected to be higher if the distance between host tissue and implanted decellularised cusp tissue is shorter. This speaks in favour of a reduction of the implant tissue to the extent of the aortic annulus and the minimal adhering myocardial and aortic cuff in order to minimise the migration distance for repopulating host cells. Second, as we have observed in this study, the actual extent of decellularisation may never reach the theoretically possible absolute value of 100%; although, by conventional methods, a virtually complete decellularisation may be present. At the current state of knowledge, the clinical relevance of ultra-structurally detected cellular microremnants is unclear. Regardless, the surgical model of a subcoronary implantation demonstrated in this article avoids the transfer of functionally unnecessary and potentially hazardous tissue to the recipient animal. Thus, the risk of chronic adverse immunological reactions on the late longterm outcome is expected to be further minimised. Furthermore, as already demonstrated for homografts or pulmonary autografts in the setting of the Ross procedure, significant dilatation of a biological neo-aortic root may occur in the late follow-up period [15] , and this appears to be true for implants of allogenic, autologous or decellularised character. The risk of graft rupture that is particularly present with the root-implantation technique and may lead to catastrophic consequences for the recipient patient cannot be overestimated. This has been demonstrated in a report by Simon et al. on paediatric patients receiving decellularised pulmonary valves as a root [16] . Therefore, in our opinion, the subcoronary-implantation technique introduced in this report as a model to study dAoVs provides excellent haemodynamic features paired with promising findings on the cellular level along with a greater procedural safety.
One of the limitations of the present study lies in the small number of study animals. A broader experience with larger numbers of animals, possibly evaluated by other groups, will strengthen the value of the data and the base for possible future clinical application. Furthermore, as with many animal models, our model is the best available model and, yet, the sheep model might leave some residual uncertainties regarding the exact concordance of the observed durability in animal versus human subjects. Finally and certainly, longer studies beyond 5 months will add to the value of the obtained data and thereby increase the safety of the first clinical application in the future.
Conclusion
The dAoVs show excellent functional outcome at 5 months in a subcoronary model of juvenile sheep. The application of the subcoronary-implantation technique is a feasible approach that may increase procedural safety by decreasing the risk of degenerative events and thereby improving longterm outcome. Advanced endothelial and nascent interstitial repopulation, with preserved structural integrity under the high-shear-stress milieu of the aortic valve, encourage further long-term studies.
